Endovascular treatment in the superficial femoral artery: which devices, where?
Endovascular interventions focused on the treatment of superficial femoral artery occlusive disease have increased exponentially as technologic advances have provided the practitioner with a wide array of treatment options. Unfortunately, there is a lack of comparative trials available to guide the practitioner in determining when these devices are best utilized. In the current report, the available comparative data, single-arm trials, and registry data are reviewed and device recommendations are proposed based on TASC II classification, lesion morphology, and indication.
Powell
Richard J
RJ
Section of Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA. Richard.Powell@Hitchcock.org
D000800:Angioplasty, Balloon / Q000295:instrumentation; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D017073:Atherectomy / Q000295:instrumentation; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation; D002317:Cardiovascular Agents / Q000627:therapeutic use; D004617:Embolism / Q000209:etiology / Q000517:prevention & control; D005263:Femoral Artery / Q000000981:diagnostic imaging; D006801:Humans; D053685:Laser Therapy; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D011859:Radiography; D015607:Stents; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation*
D002317:Cardiovascular Agents